Jyothy Labs Ltd (JYOTHYLAB)
🎯 Key Takeaways
- Jyothy Labs is in a transitional phase marked by modest top-line growth amid persistent margin pressure from elevated input costs, despite resilient volume trends in core segments like Fabric and Home Care. Management is focused on margin recovery through pricing discipline and innovation, while navigating a challenging macro environment with crude-linked inflation.
- Revenue declined 5.3% QoQ to ₹667 in Q4FY25.
- ⚠️ Persistent input cost inflation from crude-linked raw materials continues to pressure gross margins, with management's H2 FY27 recovery contingent on
📖 The Story
Jyothy Labs is in a transitional phase marked by modest top-line growth amid persistent margin pressure from elevated input costs, despite resilient volume trends in core segments like Fabric and Home Care. Management is focused on margin recovery through pricing discipline and innovation, while navigating a challenging macro environment with crude-linked inflation. The company maintains a strong balance sheet with zero net debt and consistent cash generation, but recent profit declines and share price weakness (-39.91% 1Y return) reflect market skepticism about near-term earnings visibility.
📰 What's Happening
In Q1 FY27 (reported August 12, 2026), revenue grew 3.0% YoY to ₹773 crores, driven by 8.1% value growth in core segments excluding Pril and Fa, with Fabric Care up 14.1% and Home Care up 2.4%. However, PAT declined sharply to ₹47.6 crores from prior periods, reflecting margin compression. The Board approved transferring the Jammu facility leasehold rights to Aikyam Flexipack for ₹9.93 crores in August 2026, targeting completion by March 31, 2027, potentially freeing up capital but reducing manufacturing footprint. At the July 14, 2026 AGM, shareholders approved the audited FY26 results and a final dividend of ₹3.50 per share, while endorsing strategic focus on the Exo brand and ESG initiatives.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 742 | 734 | 704 | 667 |
| Operating Profit | 120 | 125 | 101 | 97 |
| OPM % | 16.2% | 17.0% | 14.4% | 14.6% |
| Net Profit | 102 | 105 | 87 | 76 |
| EPS | ₹2.77 | ₹2.86 | ₹2.38 | ₹2.08 |
Quarterly revenue has shown a gradual decline from ₹742 crores in June 2024 to ₹667 crores in March 2025, despite stable operating margins around 14-16%. Net profit has also trended downward from ₹105 crores in September 2024 to ₹76 crores in March 2025, with EPS falling from ₹2.86 to ₹2.08 over the same period. This trend aligns with management's commentary on margin pressure from 30-35% crude-linked input cost inflation, which reduced gross margins from 48% to 38% in Q1 FY27. While volume growth remains positive in core segments, the sequential decline in profitability suggests that cost inflation is outpacing pricing gains, even as management targets H2 FY27 margin recovery contingent on crude stabilization.
🔮 Management Outlook & What's Next
Management expects margin improvement in the second half of FY27 as input cost inflation moderates, supported by innovation, premiumisation, and calibrated pricing actions. They highlighted that pricing increases of 3% were implemented in Q1 FY27, with plans for further calibrated hikes, and emphasized double-digit revenue growth targets for FY27 excluding Pril and Fa. However, no specific revenue or margin targets were provided during the concall on June 30, 2026. The focus remains on sustaining volume growth in modern trade, e-commerce, and quick commerce channels, while developing the Exo brand as an owned platform for long-term differentiation and margin expansion.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2024 | Mar 2024 | Mar 2025 | Mar 2025 |
|---|---|---|---|---|
| Equity Capital | 37 | 37 | 37 | 37 |
| Reserves | 1,603 | 1,772 | 1,849 | 2,013 |
| Borrowings | 45 | 51 | 56 | 0 |
| Total Liabilities | 2,220 | 2,401 | 2,526 | 2,691 |
| Fixed Assets | 325 | 333 | 337 | 1,141 |
| Investments | 5 | 192 | 288 | 456 |
| Total Assets | 2,220 | 2,401 | 2,526 | 2,691 |
The balance sheet remains exceptionally strong with zero net debt and consistently rising equity and reserves over the past three fiscal years. As of March 2025, total assets stood at ₹2,691 crores with equity of ₹37 crores and reserves of ₹2,013 crores, up from ₹1,772 crores in March 2024. Borrowings remain minimal at ₹56 crores in March 2025, down from ₹51 crores a year earlier, indicating no leverage increase. This financial discipline supports strategic flexibility, including the recent ₹9.93 crore asset transfer, but the lack of debt also limits financial engineering options to offset margin pressures.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +311 |
| Investing | -161 |
| Financing | -157 |
| Net Cash Flow | -7 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 62.9% | 62.9% | 62.9% | 62.9% |
| FII | 12.1% | 12.8% | 12.3% | 12.1% |
| DII | 16.1% | 15.1% | 14.6% | 13.4% |
| Public | 7.6% | 7.8% | 8.6% | 9.9% |
| # Shareholders | 2,17,305 | 2,23,801 | 2,33,314 | 2,47,104 |
Institutional investor interest has remained relatively stable, with FII holding at 12.13% in Q1 FY27 (down slightly from 12.35% in Q4 FY26), while DII holdings declined from 16.08% in Q2 FY26 to 13.37% in Q1 FY27. Promoter holding remains steady at 62.89% across all quarters. The growing number of shareholders — from 2,17,305 in Q2 FY26 to 2,47,104 in Q1 FY27 — suggests retail participation is increasing, possibly reflecting retail investor confidence or index inclusion. However, the sustained promoter stake and stable institutional holdings indicate no major shifts in ownership structure despite share price declines.
⚖️ Peer Comparison — FMCG
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| HINDUNILVR | 4.69 L Cr | 31.3 | 29.8% | 30.7% | 0.00 |
| ITC | 3.34 L Cr | 16.8 | 36.0% | 27.8% | 0.03 |
| NESTLEIND | 2.78 L Cr | 73.0 | 99.2% | 73.9% | 0.00 |
| VBL | 1.37 L Cr | 40.6 | 21.5% | 17.4% | 0.10 |
| BRITANNIA | 1.25 L Cr | 47.9 | 54.1% | 51.1% | 0.27 |
| LENSKART | 1.15 L Cr | 173.3 | 11.9% | 7.7% | 0.03 |
| MARICO | 1.09 L Cr | 57.3 | 54.2% | 46.4% | 0.08 |
| TATACONSUM | 1.02 L Cr | 62.2 | 10.2% | 8.0% | 0.10 |
| GODREJCP | 92,112 | 48.1 | 17.8% | 15.1% | 0.33 |
| DABUR | 68,173 | 34.6 | 21.3% | 17.1% | 0.09 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Persistent input cost inflation from crude-linked raw materials continues to pressure gross margins, with management's H2 FY27 recovery contingent on crude price stability — a material uncertainty. 2. Margin compression is evident in both EBITDA (8.4% in Q1 FY27 vs historical 18-20%) and PAT trends, with no clear timeline for full recovery despite pricing actions. 3. Core segment growth is decelerating in Home Care (2.4% excluding Pril), raising concerns about volume sustainability. 4. The sale of the Jammu facility, while capital-light, may reduce operational capacity and is not a scalable solution to margin challenges.
📋 Recent Filings
-
🔴 Announcement 1 September 2026Jyothy Labs announced an investor meeting on September 3, 2026, with ICICI Securities, to discuss its business outlook and share updates. The session ...
-
Announcement 25 August 2026Jyothy Labs Limited disclosed an excise duty order from the Central Goods and Services Tax Commissionerate covering April 2016 to June 2017, raising a...
-
Announcement 12 August 2026Jyothy Labs reported a 3% revenue increase to ₹773 crores in Q1 FY27, but gross margin fell to 38.5% from 48% year-on-year due to raw material and pac...
-
🟡 Board Meeting 12 August 2026Jyothy Labs announced the board's approval to transfer leasehold rights of its Jammu manufacturing facility to Aikyam Flexipack for approximately ₹9.9...
-
🟡 Board Meeting 12 August 2026Jyothy Labs reported unaudited Q1 FY27 results (ended June 30, 2026) showing revenue of **₹79,105 lakhs**, up from ₹73,320 lakhs in Q1 FY26, with net ...
-
Announcement 12 August 2026Jyothy Labs announced that an audio recording of its August 12, 2026 conference call discussing Q1 FY26 results is now available via a public link, al...
-
🔴 Financial Results 12 August 2026Jyothy Labs reported Q1 FY27 revenue of **₹773 crores**, up 3.0% YoY, with core revenue (excluding Pril and Fa) growing 8.1% in value and 5.3% in volu...
-
Announcement 31 July 2026Jyothy Labs announced that CRISIL ESG Rating & Analytics assigned an ESG rating of CRISIL ESG 62 under the Strong category for FY 2025-26, based on pu...
-
🟡 Board Meeting 14 July 2026Jyothy Labs held its 35th Annual General Meeting on July 14, 2026 via video conference, with 64 shareholders representing 47.64% of equity present. Th...
-
🟡 concall transcript 30 June 2026Jyothy Labs reported Q1 FY27 revenue growth of 8.1% driven by volume and pricing, with gross margins under pressure from 48% to 38% due to 30-35% crud...
🧠 Analyst's Read
Jyothy Labs is navigating a critical inflection point where margin recovery hinges on crude price trends and successful execution of pricing and innovation strategies. While the strong balance sheet and resilient core segments provide a foundation, the declining profitability and share price performance underscore execution risks. Investors should monitor H2 FY27 margin trends, crude input cost developments, and the pace of Exo brand monetization as key near-term catalysts.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-02.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when JYOTHYLAB files new disclosures
Track JYOTHYLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track JYOTHYLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd